StockWatch
·

Satin Creditcare Network Ltd

BSE: 539404

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
812.11
+20.9%+13.4%
Expenditure
583.81
+13.7%-10.1%
Net Profit
171.61
+42.7%+230.8%
OPM %
63.27%
+8.08pp+9.51pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00227.40454.79682.19909.59Q1 FY19Q2 FY19Q3 FY19Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Profitability surge on credit discipline; growth deliberately paced

credit quality · profitability · AUM growth

Result verdictFollow-upQ2 FY2703 Nov 20266 minFinancial Services

Exceptional credit quality, modest growth weigh on outlook

credit quality · profitability surge · slippage reduction

TranscriptDeep diveQ2 FY2703 Nov 20266 minFinancial Services

Satin Creditcare Q2 FY27: consolidated PAT up 231% YoY to ₹176 Cr as credit costs normalize

nbfc · microfinance · credit cost normalization

ResultsQ2 FY2728 Oct 20263 minFinancial Services
Latest
Quarterly Result28 Oct, 4:06 pm

Satin Creditcare Q2 FY27: consolidated PAT up 231% YoY to ₹176 Cr as credit costs normalize

Satin Creditcare's consolidated PAT came in at ₹175.9 Cr for Q2 FY27, up 231% YoY from ₹53.2 Cr and 43% QoQ from ₹122.6 Cr, on revenue from operations of ₹925.8 Cr (+17.5% YoY, +21.5% QoQ). EPS rose to ₹15.98 from ₹4.83 a year ago. Standalone PAT of ₹171.6 Cr (EPS ₹15.59) tracks almost identically with consolidated — the four subsidiaries (Satin Housing Finance, Satin Finserv, Satin Technologies, Satin Growth Alternatives) plus step-down QTrino Labs together added only ₹6.66 Cr of PAT for the quarter, confirming the core NBFC-MFI lending book, not the newer bets, drove the print. We have no verified Street consensus for this specific quarter's PAT to grade the print against (vsStreet: unknown); broader analyst commentary around the FY27 opening had pointed to 15-20% full-year PAT growth, a bar this quarter's YoY print already runs well ahead of on a standalone basis. The swing is a margin story, not a volume story: net profit margin expanded to roughly 18.9% of total income from 6.7% a year ago and 16.0% last quarter. Consolidated impairment on financial instruments fell to ₹89.6 Cr from ₹143.3 Cr a year earlier (-37.5% YoY) and from ₹106.1 Cr last quarter, even as the book grew — this is the primary driver of the earnings jump, consistent with management's prior framing of FY27 as a credit-cost normalization year. That improvement came despite finance costs rising to ₹339.2 Cr (consolidated) from ₹270.1 Cr YoY as the balance sheet was funded with more debt (five NCD tranches totaling ₹43,500 lakh were placed during the quarter, per the filing's notes). Against management's own guidance from the Q1 FY27 call — FY27 consolidated AUM growth of 20-25% to ₹18,200-18,900 Cr by March 2027, standalone credit cost of 3-3.5%, and standalone ROA of 3.5-4% — this quarter's business update (Oct 7, 2026) put consolidated AUM at ₹16,600 Cr, up 31% YoY, already running ahead of the guided growth range with two quarters left in the year. The sharp fall in impairment is directionally consistent with credit costs normalizing toward the guided band, though the filing does not disclose a standalone credit-cost or ROA ratio to confirm the exact figure. Management had also flagged that it would review guidance at the half-year mark based on the monsoon — this result is that checkpoint, and the tone implied by the numbers (AUM ahead of plan, credit costs falling) reads as on-track-to-ahead rather than a reason to cut targets. No company press release was available in our records for this result to cross-check against management's own characterization of the quarter. Asset quality on the standalone book remains comfortable, with GNPA at 1.94%, NNPA at 0.17% and provision coverage of 91.46%, alongside CRAR of 27.89% and a liquidity coverage ratio of 131.91% — none of which signal stress accompanying the growth. Consolidated leverage (debt-equity 3.81x) runs ahead of standalone (2.92x) as the subsidiaries layer on additional debt-funded growth, including ₹110 Cr of rights-issue capital into Satin Finserv and ₹12 Cr into Satin Growth Alternatives during the quarter. Going into Q3, the trajectory to watch is whether impairment keeps falling at this pace as the book scales past ₹16,600 Cr, since that — not AUM growth, which is already ahead of plan — is what will determine whether the margin expansion holds.

28 Oct 2026, 04:06 pm

Corporate Events

Board MeetingSATIN
2026
28Oct

Board Meeting

The Board of Directors meeting is scheduled to consider and …

BSE Filing ↗
Board MeetingSATIN
2026
7Aug

Board Meeting

The 36th Annual General Meeting ("AGM") of the Members of th…

BSE Filing ↗
Board MeetingSATIN
2026
30Jul

Board Meeting

A meeting of the Board of Directors of M/s Satin Creditcare …

BSE Filing ↗
Board MeetingSATIN
2026
23Jun

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingSATIN
2026
4Jun

Board Meeting

The board meeting is scheduled to consider and approve the p…

BSE Filing ↗
Board MeetingSATIN
2026
16Mar

Board Meeting

To consider and approve fund raising proposal by way of issu…

BSE Filing ↗
Board MeetingSATIN
2025
14Jul

Board Meeting

Board Meeting Intimation, fund raising proposal by way of is…

BSE Filing ↗
Board MeetingSATIN
2024
8Nov

Board Meeting

consider and approve Unaudited Financial Results (Standalone…

BSE Filing ↗
Board MeetingSATIN
2024
20Sep

Board Meeting

Fund raising proposal

BSE Filing ↗
Board MeetingSATIN
2024
11Sep

Board Meeting

Consider and approve proposal for raising funds

BSE Filing ↗
Board MeetingSATIN
2024
9Aug

Board Meeting

Fund raising proposal

BSE Filing ↗
Board MeetingSATIN
2024
31Jul

Board Meeting

consider and approve Unaudited Financial Results (Standalone…

BSE Filing ↗
Board MeetingSATIN
2024
24Jun

Board Meeting

Funds Raising

BSE Filing ↗
Board MeetingSATIN
2024
29Apr

Board Meeting

Consider and approve Audited Financial Results (Standalone a…

BSE Filing ↗
Board MeetingSATIN
2024
28Mar

Board Meeting

Consider and approve raising of funds by way of issuance of …

BSE Filing ↗
Board MeetingSATIN
2024
2Feb

Board Meeting

Consider and approve Unaudited Financial Results (Standalone…

BSE Filing ↗
Board MeetingSATIN
2024
15Jan

Board Meeting

Consideration and approval of proposal to raise funds by way…

BSE Filing ↗
Board MeetingSATIN
2024
8Jan

Board Meeting

consider and approve the fund raising proposal

BSE Filing ↗
Board MeetingSATIN
2023
30Nov

Board Meeting

Consider and approve fund raising proposal by way of issuanc…

BSE Filing ↗
Board MeetingSATIN
2023
20Nov

Board Meeting

consider and approve the fund raising proposal by way of iss…

BSE Filing ↗
Board MeetingSATIN
2023
1Nov

Board Meeting

consider and approve the fund raising proposal

BSE Filing ↗
Board MeetingSATIN
2023
27Oct

Board Meeting

Consider and approve the unaaudited financial results (stand…

BSE Filing ↗
Board MeetingSATIN
2023
20Oct

Board Meeting

Consider and approve fund raising proposal

BSE Filing ↗
Board MeetingSATIN
2023
19Oct

Board Meeting

Consider and approve the proposal for raising of funds

BSE Filing ↗
Board MeetingSATIN
2023
6Oct

Board Meeting

Consideration and approval of Raising of funds by way of iss…

BSE Filing ↗
Board MeetingSATIN
2023
11Aug

Board Meeting

Consider and approve fund raising proposal by way of issuanc…

BSE Filing ↗
Board MeetingSATIN
2023
3Aug

Board Meeting

Consider and approve the fund raising proposal by way of iss…

BSE Filing ↗